HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY HZNP Balance Sheet

Horizon therapeutics public limited company (HZNP)

Balance Sheet / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Dec'10
ASSETS
CURRENT ASSETS:
Cash and cash equivalents
754	1,076	883	865	1,032	958	807	710	674	751	624	554	603	509	549	424	385	859	684	667	544	218	248	128	103	80	58	69	81	104	121	63	80	17	32	5	5
Restricted cash
3	3	3	3	3	3	6	6	6	6	6	7	6	7	5	3	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accounts receivable, net
425	408	396	395	403	464	391	403	404	405	390	390	396	305	362	304	290	210	221	182	127	73	80	51	40	15	16	7	7	3	5	0	0	2	0	0	0
Inventories, net
68	53	58	51	51	50	53	50	47	61	86	102	137	174	162	172	180	18	17	20	13	16	23	9	9	8	6	5	4	5	3	3	2	1	1	0	0
Prepaid expenses and other current assets
161	143	135	85	67	68	81	64	52	43	52	45	52	49	38	33	17	15	16	11	48	14	7	7	9	4	2	3	2	3	4	4	4	2	1	0	0
Deferred tax assets, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13	15	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total current assets
1,413	1,686	1,478	1,401	1,559	1,545	1,339	1,234	1,185	1,268	1,161	1,100	1,197	1,046	1,117	938	876	1,106	953	898	735	324	360	197	162	110	85	86	96	116	136	72	88	25	36	6	7
Property and equipment, net
142	30	26	24	22	20	16	18	19	20	21	22	23	23	21	21	18	14	10	9	8	7	4	4	3	3	3	3	3	3	3	3	3	3	2	2	2
Intangible assets, net
1,749	1,702	1,760	1,818	1,892	1,950	2,209	2,277	2,344	2,447	2,518	2,586	2,703	2,773	1,883	1,934	1,983	1,616	1,657	1,699	687	704	743	120	125	131	65	64	65	68	68	32	35	35	38	41	39
In-process research and development
-	-	-	-	-	-	-	-	-	-	-	-	-	-	66	66	66	66	66	66	66	66	-	-	-	-	-	-	-	-	-	35	37	36	111	118	108
Other intangible assets, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6	-	7	7	-	7	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill
413	413	413	413	413	413	426	426	426	426	426	427	445	445	248	255	255	253	259	259	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Long-term investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	42	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred tax assets, net
552	555	0	6	2	3	0	4	0	3	5	2	1	0	5	4	4	2	-	-	18	20	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other assets
42	48	42	43	44	8	27	29	26	36	36	29	2	2	6	6	0	0	9	9	10	11	15	6	6	6	3	3	4	4	3	4	4	0	0	3	3
Total assets
4,314	4,436	3,721	3,708	3,935	3,941	4,019	3,989	4,002	4,202	4,169	4,169	4,374	4,292	3,349	3,227	3,205	3,058	2,998	2,942	1,527	1,114	1,124	328	299	252	158	158	169	193	212	148	169	101	189	172	161
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES:
Convertible debt, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4	22	48	116	114	-	-	15	15	15	11	7	3	-	3	2	1	4
Long-term debt, current portion
-	-	-	-	250	-	-	-	38	10	8	8	8	7	4	4	4	4	4	4	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts payable
50	21	26	42	36	30	64	31	41	34	32	81	87	52	65	58	69	16	62	26	21	21	22	15	10	9	5	5	4	5	6	7	8	8	3	5	2
Accrued expenses
205	235	204	188	197	215	194	173	180	175	162	112	144	182	157	75	89	100	84	79	46	46	39	19	44	15	22	20	15	16	12	11	9	8	6	6	6
Accrued trade discounts and rebates
336	466	404	398	406	457	359	449	429	501	435	413	413	297	268	220	224	183	124	136	78	76	70	37	-	8	-	-	-	-	-	-	-	-	-	-	-
Accrued royalties—current portion
-	-	-	-	-	-	65	65	65	65	62	61	60	61	59	58	54	51	45	42	25	25	25	14	11	8	-	-	-	-	-	-	-	-	-	-	-
Deferred revenues, current portion
-	-	-	7	4	4	6	5	3	6	5	4	2	3	1	1	1	1	1	2	1	1	1	2	3	1	1	1	2	2	3	3	2	3	1	1	1
Deferred tax liabilities, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bridge notes payable to related parties
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	16	10
Total current liabilities
592	723	635	636	895	708	691	725	759	794	707	681	717	605	556	418	442	357	321	290	196	218	276	204	69	43	45	43	37	36	31	26	20	23	14	31	25
LONG-TERM LIABILITIES:
Exchangeable notes, net
356	351	346	341	336	332	327	323	318	314	310	306	301	298	294	290	286	282	278	274	269	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Long-term debt, net
1,001	1,001	1,000	1,025	1,021	1,564	1,563	1,562	1,547	1,576	1,578	1,577	1,578	1,501	849	849	849	849	858	858	297	297	297	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Convertible debt, net of current
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	297	0	112	110	29	31	34	36	39	47	50	15	17	19	10
Derivative liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	313	109	-	-	-	-	-	-	-	-	-	-	-
Accrued royalties, net of current
-	-	-	-	-	-	295	293	291	279	268	268	273	272	169	170	172	123	125	128	45	48	53	30	21	24	-	-	-	-	-	-	-	-	-	-	-
Deferred revenues, net of current
-	-	-	-	-	-	-	-	-	9	9	7	7	7	8	8	8	8	9	10	7	8	8	9	8	9	9	9	9	9	8	8	6	5	6	5	4
Deferred tax liabilities, net
89	94	112	109	108	107	156	157	157	157	226	210	242	296	95	131	133	113	142	121	19	20	4	3	2	3	3	3	3	4	4	8	-9	9	-24	-26	-24
Other long-term liabilities
85	80	69	74	69	38	68	67	67	68	67	88	46	46	14	20	19	9	4	4	3	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total long-term liabilities
1,533	1,527	1,530	1,550	1,536	2,043	2,410	2,403	2,382	2,406	2,461	2,459	2,451	2,422	1,431	1,470	1,470	1,387	1,418	1,397	642	355	363	43	458	258	42	44	47	51	-	-	-	31	-	-	39
TOTAL LIABILITIES
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	83	90	87	-	62	83	-
COMMITMENTS AND CONTINGENCIES
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SHAREHOLDERS’ EQUITY:
Convertible preferred stock, $0.0001 par value per share; 28,950,000 and 27,400,000 shares authorized at June 30, 2011 and December 31, 2010, respectively; 24,961,340 shares issued and outstanding at June 30, 2011 and December 31, 2010 (Liquidation preference: $177,002 at June 30, 2011 and December 31, 2010)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-
Ordinary shares, $0.0001 nominal value; 600,000,000 shares authorized at March 31, 2020 and December 31, 2019; 190,962,613 and 188,402,040 shares issued at March 31, 2020 and December 31, 2019, respectively, and 190,578,247 and 188,017,674 shares outstanding at March 31, 2020 and December 31, 2019, respectively
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Treasury stock, 384,366 ordinary shares at March 31, 2020 and December 31, 2019
4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Additional paid-in capital
2,814	2,797	2,761	2,743	2,722	2,374	2,337	2,306	2,274	2,248	2,212	2,177	2,144	2,119	2,086	2,057	2,026	2,001	2,000	1,969	1,435	1,269	1,182	774	436	410	426	422	418	417	416	329	328	270	268	208	206
Accumulated other comprehensive loss
-2	-1	-2	-1	-2	-1	-1	-1	-0	-0	-2	-2	-2	-3	-2	-2	-2	-2	-32	-2	-2	-4	-3	-2	-2	-2	-2	-3	-4	-3	-4	-4	-2	-3	0	6	-2
Accumulated deficit
-619	-605	-1,198	-1,216	-1,211	-1,178	-1,414	-1,440	-1,408	-1,242	-1,205	-1,141	-931	-848	-717	-711	-726	-681	-705	-708	-740	-720	-689	-691	-663	-457	-354	-348	-330	-308	-283	-266	-244	-220	-143	-126	-107
Total shareholders’ equity
2,188	2,185	1,555	1,520	1,504	1,190	916	860	861	1,001	999	1,028	1,205	1,263	1,361	1,338	1,291	1,313	1,258	1,253	687	540	485	80	-229	-49	69	70	84	105	128	57	81	45	126	89	97
Total liabilities and shareholders' equity
4,314	4,436	3,721	3,708	3,935	3,941	4,019	3,989	4,002	4,202	4,169	4,169	4,374	4,292	3,349	3,227	3,205	3,058	2,998	2,942	1,527	1,114	1,124	328	299	252	158	158	169	193	212	148	169	101	189	172	161
Developed Technology [Member]
Intangible assets, net
1,745	1,698	1,756	1,813	1,888	1,945	2,204	2,272	2,338	2,442	2,512	2,580	2,697	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Customer Relationships [Member]
Intangible assets, net
3	3	4	4	4	4	4	5	5	5	5	5	6	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-